Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.02. | Baudax Bio, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.02. | NSE - Baudax Bio, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
13.02. | Delisting of Securities of Sono Group N.V.; Baudax Bio, Inc.; Comera Life Sciences Holdings, Inc.; Missfresh Limited; Rose Hill Acquisition Corporation; Axcella Health; Zivo Bioscience, Inc.; Sonic Foundry, Inc.; Mobiquity Technologies, Inc. and others | 284 | GlobeNewswire (Europe) | NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group N.V.'s securities were suspended on July 21, 2023... ► Artikel lesen | |
13.12.23 | Baudax Bio, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
20.11.23 | Baudax Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
15.11.23 | Baudax Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 4 | SEC Filings | ||
15.11.23 | Baudax Bio, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
03.11.23 | Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview | 2 | Reuters | ||
25.10.23 | Baudax Bio, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
13.10.23 | Baudax Bio, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
06.10.23 | Baudax Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
02.10.23 | Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag | 3 | Zacks | ||
23.08.23 | Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock | 262 | GlobeNewswire (Europe) | MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ: BXRX), a biotechnology company focused on developing T cell receptor ("TCR") therapies utilizing... ► Artikel lesen | |
16.08.23 | Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update | 231 | GlobeNewswire (Europe) | Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg Asset for Hemophilia A Continuing to Advance Neuromuscular Blockade (NMB) Portfolio... ► Artikel lesen | |
30.06.23 | Baudax Bio Acquires TeraImmune, Inc. | 408 | GlobeNewswire (Europe) | TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax Baudax Bio CEO Gerri Henwood to Serve as CEO of... ► Artikel lesen | |
12.05.23 | Baudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business Update | 1.092 | GlobeNewswire (Europe) | Announced Positive Top-Line Final Results from Phase 2 Randomized Clinical Trial of BX1000 Hosted Key Opinion Leader Webinar to Highlight Potential of BX1000 and Neuromuscular Blocking Agent Portfolio... ► Artikel lesen | |
01.05.23 | Baudax Bio, Inc.: Baudax Bio Announces Closing of $4 Million Public Offering | 194 | GlobeNewswire (Europe) | MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ: BXRX), a pharmaceutical company focused on innovative products for hospital and related settings... ► Artikel lesen | |
27.04.23 | Baudax Bio, Inc.: Baudax Bio Announces Pricing of $4 Million Public Offering | 255 | GlobeNewswire (Europe) | MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ: BXRX), a pharmaceutical company focused on innovative products for hospital and related settings... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MPH HEALTH CARE | 21,200 | -2,30 % | EQS-News: MPH Health Care AG verkauft 1,5 Mio. Aktien ihrer Beteiligung M1 Kliniken AG an deren Vorstände | EQS-News: MPH Health Care AG
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
MPH Health Care AG verkauft 1,5 Mio. Aktien ihrer Beteiligung M1 Kliniken AG an deren Vorstände... ► Artikel lesen | |
SOLIGENIX | 0,594 | -2,16 % | SOLIGENIX, INC.: Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results | PRINCETON, N.J., March 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products... ► Artikel lesen | |
DMK PHARMACEUTICALS | 0,049 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 2 | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameLU0102219945 G.SACHS... ► Artikel lesen | |
QUALIGEN THERAPEUTICS | 0,349 | -4,77 % | Qualigen Therapeutics, Inc. - 8-K, Current Report | ||
CHARLOTTES WEB | 0,198 | +7,03 % | Earnings call: Charlotte's Web Holdings outlines strategic focus in Q4 | ||
ACLARIS THERAPEUTICS | 1,130 | -0,88 % | Aclaris Therapeutics, Inc.: Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis | - ATI-1777 2% BID Achieved a Statistically Significant Result in the Primary Efficacy Endpoint at Week 4 - - Minimal Systemic Exposure Supports "Soft" Topical JAK Inhibitor Approach - - ATI-1777... ► Artikel lesen | |
AVENUE THERAPEUTICS | 0,144 | +3,68 % | Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 | ||
AMPIO | 0,820 | 0,00 % | Ampio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistration | ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily... ► Artikel lesen | |
PETROS PHARMACEUTICALS | 1,470 | 0,00 % | Petros Pharmaceuticals, Inc. - 8-K, Current Report | ||
LUCY SCIENTIFIC DISCOVERY | 1,370 | +2,24 % | Pre-market Movers: Geron, Jet.AI, Zeo Energy, Cardlytics, Lucy Scientific Discovery | SAN JOSE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.00 A.M. ET).In the Green Geron Corporation (GERN) is up over 80% at $3.15.
Jet.AI... ► Artikel lesen | |
BAYER | 28,430 | +0,04 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.03.2024... ► Artikel lesen | |
MERCK KGAA | 163,60 | +2,12 % | Merck KGaA-Aktie: Kurs legt zu (115,6267 €) | Die Aktie von Merck KGaA notiert am Montag ein wenig fester. Der jüngste Kurs betrug 125,30 US-Dollar. Das Wertpapier von Merck KGaA verzeichnet aktuell einen Wertanstieg von 1,17 Prozent. Es hat sich... ► Artikel lesen | |
CANOPY GROWTH | 8,040 | +0,88 % | Hausse! Canopy Growth, Aurora, Tilray und Co feiern deutsche Cannabis-Freigabe | Die am Freitag durch den Bundesrat erfolgte Teil-Legalisierung von Cannabis in Deutschland sorgt für haussierende Kurse der kanadischen Cannabis-Firmen. Vereinzelt gibt es Kursgewinne von über 40 Prozent.... ► Artikel lesen | |
NOVO NORDISK | 119,48 | +0,15 % | Novo Nordisk: Nächste Zulassung in Sicht | Europas wertvollster börsennotierter Konzern steht vor allem wegen seiner Semaglutid-basierten Produkte Wegovy und Ozempic derzeit in den Schlagzeilen. Novo Nordisk hat allerdings weitere vielversprechende... ► Artikel lesen | |
ELI LILLY | 722,00 | +0,21 % | Blockbuster-Wettrennen: Kann die Novo Nordisk-Aktie mit diesem Mittel Eli Lilly überflügeln? | Die Pharmakonzerne Novo Nordisk und Eli Lilly liefern sich gerade ein heißes Rennen um die besten Abnehmpräparate. Wer hat demnächst die Nase vorn? Zuletzt konnte der amerikanische Konzern Eli Lilly... ► Artikel lesen |